Evidence map›Paper›PMID 40101777›Full record

ArticleJournal of the Royal Society, Interface2025

Reducing transmission in multiple settings is required to eliminate the risk of major Ebola outbreaks: a mathematical modelling study.

Abbie Evans, William Hart, Stefano Longobardi, Rajat Desikan, Anna Sher, Robin Thompson

Abstract read
In one paragraph

Article in Journal of the Royal Society, Interface, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Abbie EvansMathematical Institute, University of Oxford, Oxford, UK.ORCID 0000-0001-9591-665X
William HartMathematical Institute, University of Oxford, Oxford, UK.ORCID 0000-0002-2504-6860
Stefano LongobardiNon-Clinical Safety, Research Technologies, GSK, Stevenage, UK.
Rajat DesikanClinical Pharmacology Modelling and Simulation, Development, GSK, Stevenage, UK.ORCID 0000-0002-0785-8187
Anna SherClinical Pharmacology Modelling and Simulation, Development, GSK, MA, USA.
Robin ThompsonMathematical Institute, University of Oxford, Oxford, UK.ORCID 0000-0001-8545-5212

Funding

Engineering and Physical Sciences Research Council
6 · The paper itself

Abstract

The Ebola virus (EV) persists in animal populations, with zoonotic transmission to humans occurring every few months or years. When zoonotic transmission arises, it is important to understand which interventions are most effective at preventing a major outbreak driven by human-to-human transmission. Here, we analyse a mathematical model of EV transmission and calculate the probability of a major outbreak starting from a single introduced case. We consider community, funeral and healthcare facility transmission and conduct sensitivity analyses to explore the effects of non-pharmaceutical interventions (NPIs) that influence these transmission routes. We find that, if the index case is treated in the community, then the elimination of transmission at funerals reduces the probability of a major outbreak substantially (from 0.410 to 0.066 under our baseline model parametrization). However, eliminating the risk of major outbreaks entirely requires combinations of measures that limit transmission in different settings, such as community engagement to promote safe burial practices and implementation of barrier nursing in healthcare facilities. In addition to generating insights into the drivers of Ebola outbreaks, this research provides a modelling framework for assessing the effectiveness of interventions at mitigating outbreaks of other infectious diseases with transmission in multiple settings.

Indexed as

Disease OutbreaksEbolavirusHemorrhagic Fever, EbolaModels, BiologicalModels, TheoreticalAnimalsHumansbranching processEbola virus diseaseinfectious disease outbreaknon-pharmaceutical interventionsprobability of a major outbreak

Identifiers

PMID40101777
PMCPMC11919492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.